AstraZeneca has made a preliminary approach to rival drugmaker Gilead Sciences about a potential merger, as per sources in what would be the biggest healthcare deal on record. The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, said sources, who added that AstraZeneca didn’t specify terms for any transaction.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2Un6Kej
